Pruritus is the worst – plain and simple. However we have only just scratched the surface with respect to why it happens in a multitude of clinical scenarios and what it could be telling us other then “SCRATCH ME.”
In this edition of the JDD Podcast, Dr. Gideon Smith, assistant professor of dermatology at Harvard Medical school, Vice Chair for Clinical Affairs in Dermatology, and Director of the Connective Tissue Diseases Clinic and Fellowship joins us to pick apart his recent study in the JDD October 2019 edition, Characterizing Pruritus in Autoimmune Connective Tissue Diseases.
At the conclusion of the eight-week treatment, the rate of success was significantly higher for patients randomized to once-daily treatment with halobetasol 0.01% lotion compared with vehicle-treated controls (P<.001 for both comparisons).
Tune in to learn how not all itch is created equal in the autoimmune connective tissue world. Determine what questions can help guide management and therapy selection. Hear how to connect with rheumatology to forge a long lasting partnership, just like itchy and scratchy.
You May Also Like
Shots, Shots, Shots: Is There Such a Thing as One Too Many?
Shots, Shots, Shots: Is There Such a Thing as One Too Many?
F around and Find Out: Failing Forward, IL-17F in Focus, and Finding New Treatment Paradigms and Friendships through Industry Collaborations
F around and Find Out: Failing Forward, IL-17F in Focus, and Finding New Treatment Paradigms and Friendships through Industry Collaborations
“Please sir, I want some more:” When Rescue Becomes Routine With Prednisone in IBD Care
